丙基硫氧嘧啶与抗中性粒细胞胞浆抗体相关小血管炎

[1] Case of propylthiouracil- induced ANCA associated small vessel vasculitis. Harper L,Cockwell P,Savage CO. Nephrology Dialysis Transplantation . 1998

[2] Antibodies to myeloperoxidase in propylthiouracil-induced autoimmune disease in the cat. Waldhauser L,Uetrecht J. Toxicology . 1996

[3] Antineutrophil cytoplasmic antibody ( ANCA )-positive cutaneous leucocytoplastic vasculitis associated with antithyroid therapy in Graves′disease. Miller RM,Savige J,Nassis L,et al. Australasian Journal of Dermatology . 1998

[4] Case of propylthiouracilinduced vasculitis associated with anti-neutrophil cytoplasmic antibody(ANCA). Kitahara T,Hiromura K,Maezawa A,et al. Clinical Nephrology . 1997

[5] The occurrence of antineutrophil cytoplasmic antibodies with specificity for proteinase 3,myeloperoxidase, and/or elastase during treatment with antithyroid drugs〔abstract〕. Cohen-Tervaert JW,Tel W,de Vries O,et al. Sarcoidosis Vasc Diffuse Lung Dis . 1996

[6] MPO-ANCA in patients with Graves′ disease, strong association with propylthiouracil therapy〔abstract〕. Honda H,Shibata T,Hara H,et al. Sarcoidosis Vasc Diffuse Lung Dis . 1996

[7] Diffuse alveolar hemorrhage and pulmonary capillaritis due to propylthiouracil. Dhillon SS,Singh D,Doe N,et al. Chest . 1999

[8] Propylthiouracil-induced rapidly progressive glomerulonephritis associated with antineutrophil cytoplasmic autoantibodies. Kudoh Y,Kuroda S,Shimamoto K,et al. Clinical Nephrology . 1997

[9] Antineutrophil cytoplasmic antibodies ( ANCA )-associated crescentic glomerulonephritis and propylthiouracil therapy. Yuasa S,Hashimoto M,Yura T,et al. Nephron . 1996

[10] Myeloperoxidase-antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis complicating the coure of Graves′disease: report of three adult cases. Tanemoto M,Miyakawa H,Hanai J,et al. American Journal of Kidney Diseases . 1995

[1] Case of propylthiouracil- induced ANCA associated small vessel vasculitis. Harper L,Cockwell P,Savage CO. Nephrology Dialysis Transplantation . 1998

[2] Antibodies to myeloperoxidase in propylthiouracil-induced autoimmune disease in the cat. Waldhauser L,Uetrecht J. Toxicology . 1996

[3] Antineutrophil cytoplasmic antibody ( ANCA )-positive cutaneous leucocytoplastic vasculitis associated with antithyroid therapy in Graves′disease. Miller RM,Savige J,Nassis L,et al. Australasian Journal of Dermatology . 1998

[4] Case of propylthiouracilinduced vasculitis associated with anti-neutrophil cytoplasmic antibody(ANCA). Kitahara T,Hiromura K,Maezawa A,et al. Clinical Nephrology . 1997

[5] The occurrence of antineutrophil cytoplasmic antibodies with specificity for proteinase 3,myeloperoxidase, and/or elastase during treatment with antithyroid drugs〔abstract〕. Cohen-Tervaert JW,Tel W,de Vries O,et al. Sarcoidosis Vasc Diffuse Lung Dis . 1996

[6] MPO-ANCA in patients with Graves′ disease, strong association with propylthiouracil therapy〔abstract〕. Honda H,Shibata T,Hara H,et al. Sarcoidosis Vasc Diffuse Lung Dis . 1996

[7] Diffuse alveolar hemorrhage and pulmonary capillaritis due to propylthiouracil. Dhillon SS,Singh D,Doe N,et al. Chest . 1999

[8] Propylthiouracil-induced rapidly progressive glomerulonephritis associated with antineutrophil cytoplasmic autoantibodies. Kudoh Y,Kuroda S,Shimamoto K,et al. Clinical Nephrology . 1997

[9] Antineutrophil cytoplasmic antibodies ( ANCA )-associated crescentic glomerulonephritis and propylthiouracil therapy. Yuasa S,Hashimoto M,Yura T,et al. Nephron . 1996

[10] Myeloperoxidase-antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis complicating the coure of Graves′disease: report of three adult cases. Tanemoto M,Miyakawa H,Hanai J,et al. American Journal of Kidney Diseases . 1995